908 organization(s) found
Stand Up To Cancer (SU2C)
US initiative that funds collaborative cancer research teams.
State Key Laboratory of Oncogenes and Related Genes (Shanghai Cancer Institute)
State-level key laboratory focused on molecular oncology, tumor microenvironment, molecular pathology, gene-therapy research — a pillar of China’s basic cancer-science infrastructure. (shsmu.edu.cn)
Step Pharma
Driving a step change in the treatment of cancer. The world leader in CTPS1 inhibition for the targeted treatment of cancer.
Stipple Bio
We are revolutionizing targeted oncology with epitope level precision to develop life changing medicines for people with cancer.
St. Jude Children's Research Hospital
US pediatric research hospital, a world reference for childhood leukemia.
STORM Therapeutics
STORM Therapeutics is a clinical-stage biotechnology company pioneering cellular reprogramming through RNA modifications to treat disease. Its world leading understanding of RNA modifying enzymes (RME) has led to the discovery of breakthrough small-molecule drugs that precisely reprogram cells through RNA biology for the treatment of cancer, inflammation, viruses and CNS diseases. Fierce Biotech named STORM as one of its 2022 “Fierce 15”.
Stylus Medicine
Our initial focus is to create in vivo CAR-T therapies. Our approach enables precise, durable CAR-T generation inside the body. These CAR-T treatments leverage a cell-targeted lipid nanoparticle (LNP) to deliver therapeutic payloads directly to immune cells in vivo. This approach has the potential to transform patient treatment, improve patient accessibility and redefine what�s possible in medicine.
Sun Yat-sen University Cancer Center (SYSUCC)
Founded 1964, a top integrated cancer centre in southern China, combining medical treatment, research, prevention, and education. Offers surgery, chemotherapy, radiotherapy, immunotherapy, gene therapy, TCM, etc. (Chine Daily Gouvernement)
SUO (Society of Urologic Oncology)
The Mission of the Society of Urologic Oncology (SUO) is to enable qualified members primarily interested in the care of patients with malignant GU diseases to meet for the purpose of discussion, development and implementation of ideas to improve care. Our Primary Objectives are to: · Stimulate research and teaching in urologic oncology · Disseminate the principles of urologic oncology to medical profession at large · Bring urologists into a Society whose work is entirely/principally in malignant disease · Being the most qualified organization on matters of urologic oncology · Standardize fellowship training in urologic oncology
Sutro Biopharma
Sutro is advancing a next-generation antibody-drug conjugate platform designed to deliver single- and dual-payload ADCs that enable meaningful breakthroughs for patients with cancer.
Swiss Cancer Research foundation
Swiss foundation that funds cancer research projects.
SWOG Cancer Research Network
Cancer clinical trials network funded by the US National Cancer Institute, with an active leukemia committee.
Syndax
At Syndax, we are determined to realize a future in which people with cancer live longer and better than ever before. We believe that it takes a community to build a great medicine, and that is why we are working to set the new standard for developing medicines in the field of oncology - one that revolves around collaboration, shared learning, and excellence. Syndax's mission is to obtain regulatory approval and commercialize drugs that extend and improve the lives of cancer patients by drawing on the newest scientific research and advances, collaborating with determined problem solvers, and identifying value in overlooked aspects of science.